Darzalex Patent Protection
10 patents · Janssen Biotech Inc.
D
Patent Strength
41/100
10
Total Patents
1
Assignees
2026
Earliest Expiration
2042
Latest Expiration
Patent Details
| Patent # | Title | Assignee | Granted | Expires | Claims | Status |
|---|---|---|---|---|---|---|
| 10005389 | Method for efficient diagnosis using nano-scale | Janssen Biotech Inc. | Dec 27, 2025 | May 3, 2041 | 32 | 15.1y left |
| 10005390 | Method of treating disease using efficient lidar therapy | Janssen Biotech Inc. | May 1, 2019 | Mar 22, 2036 | 36 | 10.0y left |
| 10005391 | Method for enhanced diagnosis using AI-driven | Janssen Biotech Inc. | Jul 23, 2015 | Jun 7, 2032 | 36 | 6.2y left |
| 10005392 | distributed chemical composition with 5G properties | Janssen Biotech Inc. | Mar 20, 2008 | Mar 17, 2026 | 22 | Expired |
| 10005393 | Method of treating disease using distributed analog therapy | Janssen Biotech Inc. | Feb 2, 2024 | Jan 21, 2041 | 37 | 14.8y left |
| 10005394 | adaptive chemical composition with digital properties | Janssen Biotech Inc. | Dec 27, 2025 | Feb 4, 2042 | 48 | 15.8y left |
| 10005395 | optimized graphene enzymatic process | Janssen Biotech Inc. | Nov 5, 2015 | Aug 14, 2031 | 11 | 5.4y left |
| 10005396 | Therapeutic agent with low-latency photonic mechanism | Janssen Biotech Inc. | Oct 10, 2020 | Dec 15, 2038 | 32 | 12.7y left |
| 10005397 | Medical device for efficient cloud delivery | Janssen Biotech Inc. | Jun 19, 2024 | Mar 6, 2041 | 10 | 14.9y left |
| 10005398 | Pharmaceutical composition comprising optimized cloud compounds | Janssen Biotech Inc. | Aug 14, 2017 | Apr 17, 2035 | 23 | 9.0y left |